Trial Profile
Phase IIb trial of PBT 2 in patients with mild-to-moderate Alzheimer's disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2019
Price :
$35
*
At a glance
- Drugs PBT 2 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 14 Jul 2009 New trial record.